Skip to main content
PeptidePicker
Find my match
Home/Peptides/ARA-290
NeuroprotectiveClinical Trials

ARA-290

Also known as: Cibinetide

An EPO-derived peptide that reverses neuropathy without stimulating red blood cell production. The gold standard for small-fiber nerve repair.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~2 minutes

Typical Dose

2–4 mg daily

Administration

Subcutaneous injection

Mechanism of Action

Activates the Innate Repair Receptor (IRR) to promote neural regeneration and halt inflammation without erythropoietic side effects.

Key Research Areas

neuroprotectiveneuropathynerve repairEPO-derived

Frequently Asked Questions

What is ARA-290?▾
An EPO-derived peptide that reverses neuropathy without stimulating red blood cell production. The gold standard for small-fiber nerve repair.
How does ARA-290 work?▾
Activates the Innate Repair Receptor (IRR) to promote neural regeneration and halt inflammation without erythropoietic side effects.
What is the recommended dosage for ARA-290?▾
The typical research dosage is 2–4 mg daily, administered via Subcutaneous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of ARA-290?▾
The half-life of ARA-290 is approximately ~2 minutes. This affects dosing frequency and timing in research protocols.
Is ARA-290 FDA approved?▾
ARA-290 is currently classified as "Clinical Trials" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.

Ready to get started with ARA-290?

Order from our COA-verified partner — free US shipping, pharmaceutical-grade quality.

99%+ purity verifiedCOA with every orderFree priority shipping
Order ARA-290

Research Disclaimer

The information provided about ARA-290 is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Neuroprotective

Cerebrolysin

FPE 1070

Cortexin

Brain Peptide Complex

Kyotorphin

L-Tyrosyl-L-Arginine · Tyr-Arg

Back to All Peptides
Order Now Take the Quiz